Vaccine | About H1N1 vaccine, H1N1vaccine production, H1N1 vaccine manufacturers

November 13, 2011

Rapid expansion of global vaccine campaign against pneumonia ‘unprecedented’

Posted by: admin : Category: Information

A global push to bring a vaccine against the bacterial cause of pneumonia to communities that need it most is ramping up quickly, expanding to nearly 60 countries in the next five years,” PBS NewsHour’s “The Rundown” reports. “At least three million child deaths could be prevented in the next decade through the global vaccine rollout, according to a new analysis published Thursday in the journal of the Royal Society of Tropical Medicine and Hygiene by health experts from Children’s Hospital Boston and Johns Hopkins University, among others,” the blog states, adding, “More new research released this week by Johns Hopkins Bloomberg School of Public Health called the rate of the rollout and its quick expansion ‘unprecedented.’” Read more…

Comments (0) : Add Comment

October 08, 2011

HIV vaccine passes phase 1 trial

Posted by: admin : Category: Facts

The news tale reports on a phase I clinical trial that assessed the safety of a new HIV vaccine in a small group of people in Spain. Read more…

Comments (0) : Add Comment

September 14, 2011

NIH-Funded Scientists Find 2009 H1N1 Pandemic Influenza Vaccine Protects Mice from 1918 Influenza Virus

Posted by: admin : Category: Information

WHAT:
Mice injected with a 2009 H1N1 pandemic influenza vaccine and then exposed to high levels of the virus responsible for the 1918 influenza pandemic do not get sick or die, report scientists funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. The new vaccine works against the ancient virus because the 1918 and the 2009 strains of H1N1 influenza share features that allow vaccine-generated antibodies to recognize both viruses. To learn more, similar challenge studies need to be conducted in other animals, including monkeys, but the investigators say their results suggest people who are vaccinated against 2009 H1N1 influenza or were exposed to the virus could have similarly cross-protective antibodies against the 1918 strain of H1N1. This finding, they add, should help allay concerns about the potential consequences of an accidental release of the 1918 influenza virus from high-containment laboratories or its possible use as a bioterror weapon.

Comments (0) : Add Comment

September 13, 2011

NIH Scientists Advance Universal Flu Vaccine

Posted by: admin : Category: Information

A universal influenza vaccine — so-called because it could potentially provide protection from all flu strains for decades — may become a reality because of research led by scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

Comments (0) : Add Comment

September 13, 2011

New Study Re-examines Bacterial Vaccine Studies Conducted During 1918 Influenza Pandemic

Posted by: admin : Category: Information

WHAT:
Secondary infections with bacteria such as Streptococcus pneumoniae, which causes pneumonia, were a major cause of death during the 1918 flu pandemic and may be vital in modern pandemics as well, according to a new article in the Journal of Infectious Diseases co-authored by David M. Morens, M.D., senior advisor to the director of the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

Comments (0) : Add Comment

September 13, 2011